1. Home
  2. DSY vs ADVM Comparison

DSY vs ADVM Comparison

Compare DSY & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSY
  • ADVM
  • Stock Information
  • Founded
  • DSY 2020
  • ADVM 2006
  • Country
  • DSY China
  • ADVM United States
  • Employees
  • DSY N/A
  • ADVM N/A
  • Industry
  • DSY
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DSY
  • ADVM Health Care
  • Exchange
  • DSY Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • DSY 58.8M
  • ADVM 59.5M
  • IPO Year
  • DSY N/A
  • ADVM 2014
  • Fundamental
  • Price
  • DSY $1.25
  • ADVM $2.22
  • Analyst Decision
  • DSY
  • ADVM Strong Buy
  • Analyst Count
  • DSY 0
  • ADVM 5
  • Target Price
  • DSY N/A
  • ADVM $26.40
  • AVG Volume (30 Days)
  • DSY 45.4K
  • ADVM 430.7K
  • Earning Date
  • DSY 02-10-2025
  • ADVM 05-14-2025
  • Dividend Yield
  • DSY N/A
  • ADVM N/A
  • EPS Growth
  • DSY 120.37
  • ADVM N/A
  • EPS
  • DSY 0.01
  • ADVM N/A
  • Revenue
  • DSY $7,323,356.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • DSY N/A
  • ADVM N/A
  • Revenue Next Year
  • DSY N/A
  • ADVM $42.58
  • P/E Ratio
  • DSY $101.45
  • ADVM N/A
  • Revenue Growth
  • DSY 16.37
  • ADVM N/A
  • 52 Week Low
  • DSY $0.75
  • ADVM $1.78
  • 52 Week High
  • DSY $6.98
  • ADVM $10.14
  • Technical
  • Relative Strength Index (RSI)
  • DSY 38.53
  • ADVM 36.90
  • Support Level
  • DSY $1.21
  • ADVM $2.10
  • Resistance Level
  • DSY $1.51
  • ADVM $2.33
  • Average True Range (ATR)
  • DSY 0.09
  • ADVM 0.24
  • MACD
  • DSY -0.03
  • ADVM 0.03
  • Stochastic Oscillator
  • DSY 0.02
  • ADVM 32.65

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: